GetTopicDetailResponse(id=27bb1289e3db, topicName=α-1-抗胰蛋白酶缺乏癥, introduction=, content=堿基編輯器 α-1-抗胰蛋白酶缺乏癥, image=null, comments=0, allHits=106, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Jul 29 16:54:39 CST 2025, time=2025-07-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503520, tagList=[TagDto(tagId=503520, tagName=α-1-抗胰蛋白酶缺乏癥)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2275324, encodeId=4da722e53245d, content=<a href='/topic/show?id=cc80121160fd' target=_blank style='color:#2F92EE;'>#堿基編輯器#</a> <a href='/topic/show?id=27bb1289e3db' target=_blank style='color:#2F92EE;'>#α-1-抗胰蛋白酶缺乏癥#</a>, objectTitle=《第二批罕見病目錄》之α-1-抗胰蛋白酶缺乏癥——疾病中向肝臟和肺部遞送堿基編輯器, objectType=article, longId=889338, objectId=8ec7889338d1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231208/1702014031203_2570354.jpg, objectUrl=/article/show_article.do?id=8ec7889338d1, replyNumber=0, likeNumber=23, createdTime=2025-07-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8ec7889338d1, moduleTitle=《第二批罕見病目錄》之α-1-抗胰蛋白酶缺乏癥——疾病中向肝臟和肺部遞送堿基編輯器, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8ec7889338d1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2275325, encodeId=0f6a22e5325ca, content=<a href='/topic/show?id=27bb1289e3db' target=_blank style='color:#2F92EE;'>#α-1-抗胰蛋白酶缺乏癥#</a>, objectTitle=《第二批罕見病目錄》之α-1-抗胰蛋白酶缺乏癥——通過協(xié)作創(chuàng)新應(yīng)對挑戰(zhàn), objectType=article, longId=889339, objectId=256f88933969, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250711/1752233857037_8538692.jpg, objectUrl=/article/show_article.do?id=256f88933969, replyNumber=0, likeNumber=21, createdTime=2025-07-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=256f88933969, moduleTitle=《第二批罕見病目錄》之α-1-抗胰蛋白酶缺乏癥——通過協(xié)作創(chuàng)新應(yīng)對挑戰(zhàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=256f88933969)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-07-29發(fā)表于上海